Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D V Jackson

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Leukemia|March 1, 1988
Low dose Ara-C for patients with myelodysplastic syndromesB L Powell, R L Capizzi, D V Jackson, et al.
Seminars in Oncology|June 1, 1985
Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemiaR L Capizzi, B L Powell, M R Cooper, et al.
Cancer|June 15, 1981
A randomized comparative trial of chemotherapy and irradiation therapy for stage II breast cancerM R Cooper, A L Rhyne, H B Muss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology AssociationD V Jackson, P J Zekan, R D Caldwell, et al.
Leukemia|January 1, 1989
Low-dose ara-C therapy for acute myelogenous leukemia in elderly patientsB L Powell, R L Capizzi, H B Muss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology AssociationH B Muss, H B Wells, E H Paschold, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignanciesB L Powell, H B Muss, R L Capizzi, et al.
Cancer|December 1, 1984
High-dose cyclophosphamide and 5-fluorouracil versus vincristine, doxorubicin, and cyclophosphamide in advanced carcinoma of the breast. A phase III study of the Piedmont Oncology Association (POA)P J Zekan, H B Muss, R L Capizzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Improvement of long-term survival in extensive small-cell lung cancerD V Jackson, L D Case, P J Zekan, et al.
Investigational New Drugs|April 1, 1992
Menogaril in the treatment of relapsed multiple myeloma. A phase II trial of the Cancer Center of Wake Forest UniversityJ M Cruz, L D Case, H B Dalton, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Leukemia|March 1, 1988
Low dose Ara-C for patients with myelodysplastic syndromesB L Powell, R L Capizzi, D V Jackson, et al.
Seminars in Oncology|June 1, 1985
Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemiaR L Capizzi, B L Powell, M R Cooper, et al.
Cancer|June 15, 1981
A randomized comparative trial of chemotherapy and irradiation therapy for stage II breast cancerM R Cooper, A L Rhyne, H B Muss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology AssociationD V Jackson, P J Zekan, R D Caldwell, et al.
Leukemia|January 1, 1989
Low-dose ara-C therapy for acute myelogenous leukemia in elderly patientsB L Powell, R L Capizzi, H B Muss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology AssociationH B Muss, H B Wells, E H Paschold, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignanciesB L Powell, H B Muss, R L Capizzi, et al.
Cancer|December 1, 1984
High-dose cyclophosphamide and 5-fluorouracil versus vincristine, doxorubicin, and cyclophosphamide in advanced carcinoma of the breast. A phase III study of the Piedmont Oncology Association (POA)P J Zekan, H B Muss, R L Capizzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Improvement of long-term survival in extensive small-cell lung cancerD V Jackson, L D Case, P J Zekan, et al.
Investigational New Drugs|April 1, 1992
Menogaril in the treatment of relapsed multiple myeloma. A phase II trial of the Cancer Center of Wake Forest UniversityJ M Cruz, L D Case, H B Dalton, et al.
Pageof 10